PARIS--(BUSINESS WIRE)--Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting the TREM-1 pathway with potential applications for acute and chronic ...

The FDA has approved Foundation Medicine's FoundationOne CDx, the first-of-a-kind comprehensive companion diagnostic test for solid tumors. The test looks for hundreds of cancer genes, providing ...

Assay will predict which patients are best suited to the therapeutic that targets the steroid sulfatase enzyme. bioMérieux agreed to develop a companion test for Ipsen’s Phase I breast cancer drug ...

On Tuesday, Adial Pharmaceuticals Inc. (NASDAQ:ADIL) announced a collaboration with Boudicca Dx, LLC, a global precision medicine testing accelerator. Under the agreement, Boudicca will support Adial ...

Will NGS Play a Role? Companion diagnostics (CDx), in vitro diagnostic devices or imaging tools that provide information essential to the safe and effective use of a corresponding therapeutic product, ...

bioMerieux and Ipsen announced that they have signed an agreement by which bioMerieux will develop a companion test for a new breast cancer drug undergoing clinical evaluation by Ipsen. The ...

The U.S. Food and Drug Administration today approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most ...

The age of precision medicine, with treatments targeted to specific patients based on a companion test identifying the need for such a treatment, is pushing the US Food and Drug Administration (FDA) ...

Foundation Medicine received a new companion diagnostic approval from the FDA for its FoundationOne CDx test—the product’s 19th indication, now for selecting breast cancer patients for treatment with ...

U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC. The drug is for women whose ...

Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved companion diagnostic for Zejula in the United States SALT LAKE CITY, March 17 ...